Skip to main content
logo
Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.600
0.00 (0.00%)
Jul 23, 2025, 8:00 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Ribonucleic Acid Therapeutics
42.35M
Log In
Log In
Log In
Log In
Upgrade
Ribonucleic Acid Therapeutics Growth
31.12%
Log In
Log In
Log In
Log In
Upgrade
Research Collaboration - Mallinckrodt Plc
-
Log In
Log In
Log In
Log In
Upgrade
Research Collaboration - Mallinckrodt Plc Growth
-
Log In
Log In
Log In
Log In
Upgrade
Research Collaboration - Other
-
Log In
Log In
Log In
Log In
Upgrade
Royalties
-
Log In
Log In
Log In
Log In
Upgrade
Royalties Growth
-
Log In
Log In
Log In
Log In
Upgrade
Research Collaboration - AstraZeneca
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United Kingdom
42.21M
Log In
Log In
Log In
Log In
Upgrade
United Kingdom Growth
33.68%
Log In
Log In
Log In
Log In
Upgrade
Germany
140.99K
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
-80.54%
Log In
Log In
Log In
Log In
Upgrade